SIDEBAR: Venous Thromboembolism Expert Panel


Get Permission

Gary H. Lyman, MD, MPH, FRCP (Edin), Co-Chair, Duke University Medical Center

Anna Falanga, MD, Co-Chair, Ospedali Riuiniti Bergamo, Italy

Daniel Clarke-Pearson, MD, University of North Carolina

Christopher Flowers, MD, MS, Winship Cancer Institute

Charles W. Francis, MD, University of Rochester Medical Center

Leigh Gates, Patient Representative, University of Colorado

Mohammad Jahanzeb, MD, University of Tennessee

Ajay Kakkar, MD, PhD, Barts and The London School of Medicine, Thrombosis Research Institute

Alok A. Khorana, MD, University of Rochester Medical Center

Nicole M. Kuderer, MD, Duke University Medical Center

Mark Levine, MD, PhD, McMaster University

Howard A. Liebman, MD, University of Southern California

David S. Mendelson, MD, Premiere Oncology

Gary Edward Raskob, PhD, University of Oklahoma Health Sciences Center

Paul A. Thodiyil, MD, New York Methodist Hospital

David Trent, MD, PhD, Virginia Cancer Center 

aAll members of the Expert Panel complied with ASCO policy on conflicts of interest. For full disclosures of the Panel members, visit www.JCO.ASCOPubs.org.


Related Articles

Updated ASCO Clinical Practice Guideline for Venous Thromboembolism Prophylaxis and Treatment

ASCO has released a new evidence-based clinical practice guideline for venous thromboembolism prophylaxis and treatment, updating the 2007 practice guideline.1 The update is based on a systematic review of literature published from December 2007 to December 2012. An Update Committee reviewed...

Venous Thromboembolism in Patients with Cancer: Real-world Challenges for the Practicing Oncologist

The close association between cancer and thrombosis has been recognized now for more than 150 years.1 Not only is it now known that patients with cancer are at substantially increased risk of developing venous thromboembolism, even prior to the diagnosis of cancer, but the association between...


Advertisement

Advertisement



Advertisement